HK1072610A1 - High level constitutive production of anthrax protective antigen - Google Patents

High level constitutive production of anthrax protective antigen

Info

Publication number
HK1072610A1
HK1072610A1 HK05105241A HK05105241A HK1072610A1 HK 1072610 A1 HK1072610 A1 HK 1072610A1 HK 05105241 A HK05105241 A HK 05105241A HK 05105241 A HK05105241 A HK 05105241A HK 1072610 A1 HK1072610 A1 HK 1072610A1
Authority
HK
Hong Kong
Prior art keywords
cells
coli
protective antigen
anthrax
followed
Prior art date
Application number
HK05105241A
Other languages
English (en)
Inventor
Bhatnagar Rakesh
Waheed Syed Mohsin
Chauhan Vibha
Original Assignee
Bhatnagar Rakesh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bhatnagar Rakesh filed Critical Bhatnagar Rakesh
Publication of HK1072610A1 publication Critical patent/HK1072610A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
  • Laminated Bodies (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
HK05105241A 2001-11-05 2005-06-23 High level constitutive production of anthrax protective antigen HK1072610A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1127DE2001 IN190590B (de) 2001-11-05 2001-11-05
PCT/IN2001/000215 WO2003040179A1 (en) 2001-11-05 2001-12-07 High level constitutive production of anthrax protective antigen

Publications (1)

Publication Number Publication Date
HK1072610A1 true HK1072610A1 (en) 2005-09-02

Family

ID=11097131

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05105241A HK1072610A1 (en) 2001-11-05 2005-06-23 High level constitutive production of anthrax protective antigen

Country Status (16)

Country Link
US (1) US7329513B2 (de)
EP (1) EP1442052B1 (de)
JP (1) JP2005510215A (de)
CN (1) CN100347189C (de)
AT (1) ATE484517T1 (de)
BR (1) BRPI0117173A2 (de)
CA (1) CA2465679A1 (de)
DE (1) DE60143276D1 (de)
HK (1) HK1072610A1 (de)
IL (1) IL161725A0 (de)
IN (1) IN190590B (de)
MX (1) MXPA04004281A (de)
RU (1) RU2288272C2 (de)
UA (1) UA80809C2 (de)
WO (1) WO2003040179A1 (de)
ZA (1) ZA200403396B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80809C2 (en) * 2001-11-05 2007-11-12 Process for preparation of protective antigen protein of anthracis with e.coli
BRPI0410562B8 (pt) 2003-05-22 2021-05-25 Fralunhofer Usa Inc proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeira
WO2004108750A1 (en) * 2003-06-06 2004-12-16 Avecia Limited Process for the separation of proteins
US20060246079A1 (en) * 2003-11-14 2006-11-02 Morrow Phillip R Neutralizing human antibodies to anthrax toxin
WO2005081749A2 (en) * 2004-01-23 2005-09-09 Avanir Pharmaceuticals, Inc. Neutralizing human antibodies to anthraxtoxin
US7355027B2 (en) 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
US8101735B2 (en) 2004-06-16 2012-01-24 Health Protection Agency Preparation of protective antigen
CN100336908C (zh) * 2004-09-10 2007-09-12 中国人民解放军军事医学科学院微生物流行病研究所 一种制备重组炭疽保护性抗原的方法及其专用表达质粒
BRPI0614475B8 (pt) 2005-08-03 2021-05-25 Fraunhofer Usa Inc polipeptídeo, anticorpo, ácido nucleico, vetores, célula hospedeira, composição e processos de produção de anticorpo
WO2008048344A2 (en) * 2006-02-13 2008-04-24 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
JP2009526526A (ja) 2006-02-13 2009-07-23 フラウンホーファー ユーエスエー， インコーポレイテッド インフルエンザ抗原、ワクチン組成物、および関連する方法
GB0607462D0 (en) * 2006-04-13 2006-05-24 Avecia Ltd Assay
EP2021021A2 (de) * 2006-05-12 2009-02-11 Oklahoma Medical Research Foundation Anthrax-zusammensetzungen und verfahren zu ihrer herstellung und anwendung
EP2044194B1 (de) 2006-06-30 2011-10-05 University Of Georgia Research Foundation, Inc. Anthrax-kohlenhydrate sowie synthese und verwendungen davon
US8420607B2 (en) * 2006-06-30 2013-04-16 University Of Georgia Research Foundation, Inc. Anthrax carbohydrates, synthesis and uses thereof
WO2009009759A2 (en) 2007-07-11 2009-01-15 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
WO2009126355A2 (en) * 2008-01-28 2009-10-15 Baxter International, Inc. Methods of increasing recombinant production of bacillus anthracis protective antigen
US8734803B2 (en) 2008-09-28 2014-05-27 Ibio Inc. Humanized neuraminidase antibody and methods of use thereof
US9616117B2 (en) * 2008-10-02 2017-04-11 Pharmathene, Inc. Anthrax vaccine formulation and uses thereof
US20100183675A1 (en) * 2009-01-22 2010-07-22 Allan Watkinson Stable vaccine compositions and methods of use
EP2483307A1 (de) 2009-09-29 2012-08-08 Fraunhofer USA, Inc. Influenza-hämagglutinin-antikörper, zusammensetzungen daraus und zugehörige verfahren
US20120301951A1 (en) * 2010-11-18 2012-11-29 E. I. Du Pont De Nemours And Company Prevention of contamination of nutrient feed reservoirs & feed lines in bioreactor systems
RU2633508C1 (ru) * 2016-12-27 2017-10-12 Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук (ФИЦ Биотехнологии РАН) Штамм E. coli - продуцент изолированного домена 1 протективного антигена Bacillus anthracis в форме вирусоподобных частиц
RU2633504C1 (ru) * 2016-12-27 2017-10-12 Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук (ФИЦ Биотехнологии РАН) Штамм E.coli - продуцент полноразмерного протективного антигена Bacillus anthracis в форме вирусоподобных частиц
CN115125224B (zh) * 2022-08-11 2023-07-18 福州大学 一种可规模化生产具有活性的dna聚合酶的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800821A (en) * 1995-03-10 1998-09-01 New England Medical Center Hospitals, Inc. Bacterial spores as a heat stable vaccine delivery system
EP1068309B1 (de) * 1998-04-07 2004-12-15 Wisconsin Alumni Research Foundation Enterotoxindefizierende bacillus
US20020086032A1 (en) * 1999-02-02 2002-07-04 Mahan Michael J. Producing antibodies with attenuated bacteria with altered DNA adenine methylase activity
WO2003055977A2 (en) * 2001-10-01 2003-07-10 Regents Of The University Of California A method for generating overexpression of alleles in genes of unknown function
UA80809C2 (en) * 2001-11-05 2007-11-12 Process for preparation of protective antigen protein of anthracis with e.coli
US7763451B2 (en) * 2001-11-09 2010-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods for preparing Bacillus anthracis protective antigen for use in vaccines

Also Published As

Publication number Publication date
ATE484517T1 (de) 2010-10-15
EP1442052A1 (de) 2004-08-04
BRPI0117173A2 (pt) 2018-04-17
IL161725A0 (en) 2005-11-20
US7329513B2 (en) 2008-02-12
IN190590B (de) 2003-08-09
UA80809C2 (en) 2007-11-12
MXPA04004281A (es) 2005-03-31
RU2288272C2 (ru) 2006-11-27
WO2003040179A1 (en) 2003-05-15
JP2005510215A (ja) 2005-04-21
CN1582298A (zh) 2005-02-16
CA2465679A1 (en) 2003-05-15
ZA200403396B (en) 2005-08-05
EP1442052B1 (de) 2010-10-13
CN100347189C (zh) 2007-11-07
US20050054038A1 (en) 2005-03-10
DE60143276D1 (de) 2010-11-25
RU2004117085A (ru) 2005-03-27

Similar Documents

Publication Publication Date Title
HK1072610A1 (en) High level constitutive production of anthrax protective antigen
CY1110494T1 (el) Μεταστροφες μεταβολικου ρυθμου σε ζυμωσεις που εκφραζουν ανασυνδυασμενες πρωτεϊνες
NZ335628A (en) Improved expression vectors comprising a nucleic acid construct with tac and gal bacterial promoters
CN112194720A (zh) 一种重组人源iii型胶原蛋白及其生产方法
EP0737747A3 (de) Cytoplasmatische Expression von Antikörpern, Antikörperfragmenten und Antikörperfragment-Fusionsmolekülen in E. coli
IL173474A0 (en) Methods for producing recombinant proteins
CN102533839B (zh) 融合表达含有二硫键蛋白质的方法
JP5662363B2 (ja) 難発現性タンパク質の分泌のためのタンパク質融合因子（ｔｆｐ）を明らかにする方法、タンパク質融合因子（ｔｆｐ）ライブラリーを製造する方法、及び難発現性タンパク質の組み換え的生産方法
WO2007015691A3 (en) Methods and compositions for increasing longevity and protein yield from a cell culture
KR100614020B1 (ko) 폴리펩티드의 재조합 생산을 위한 향상된 방법
AU2003237061A1 (en) Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same
Maleki et al. High expression of methylotrophic yeast-derived recombinant human erythropoietin in a pH-controlled batch system
Kawasaki et al. Folding-Dependentin VitroProtein Splicing of theSaccharomyces cerevisiae VMA1Protozyme
CN104151407B (zh) 一种制备人妊娠特异性糖蛋白9的方法
CN101921315B (zh) 一种人工合成的信号肽及其应用
CA2082802C (en) Method for expressing polypeptides in cyanobacteria
KR100798894B1 (ko) 재조합단백질 생산용 단백질융합인자
RU2230781C1 (ru) Штамм дрожжей saccharomyces cerevisiae 1-60-д578 (msil), - продуцент рекомбинантного интерлейкина-2 человека и способ его получения
Kunes et al. Expression of antibodies using single‐open reading frame vector design and polyprotein processing from mammalian cells
AU696454B2 (en) Family of peptides known as xenoxins
Bahrami et al. Production of recombinant human granulocyte-colony stimulating factor by Pichia pastoris
Schendel Overview of Protein Expression in E. coli
KR920009502B1 (ko) 인간 초산화물 불균화 효소(Cu, Zn-SOD) 발현운반체 (pYLBC-A/G-SOD) 및 그의 제조방법
Esipov et al. Recombinant Thymosin α1
KR100505744B1 (ko) 단백질의 수용성 형태로의 생산을 위한 무세포단백질생산방법

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111207